LORENIL CREAM 15G 2%

LORENIL 2% CREMA

active ingredients

100 g cream contain: active ingredient fenticonazole nitrate 2 g. Excipients: hydrogenated lanolin; cetilic alcohol For the full list of excipients see paragraph 6.1.

Excellent

Propilen glycol; hydrogenated lanolin; sweet almond oil; polyglycolic ester of fatty acids; cetilic alcohol; gliceril monostearate; sodium edetate; purified water.

Therapeutic indications

– Dermatomycosis from dermatophytes (Trichophyton, Microsporum, Epidermiphyton) to different location: tinea capitis, tinea corporis, tinea cruris, tinea pedis (foot of the athlete), tinea manuum, tinea faciei, tinea barbae, tinea unguium. – Candidiasis of the skin (intertrigo, perleche, facial candidiasis, candidiasis from diapers, perineal and scrotal); balaniti, balanopostiti, onichia and paronichia. – Pityriasis versicolor (from Pityrosporum orbiculare and P. oval). – Otomycosis (from Candida or mold); only if there are no tympan injuries. – Eritrasma. – Mycosis with bacterial superinfections (from Gram positive bacteria).

Contraindications

Hypersensitivity to the active ingredient or any of the excipients.

Population

Lorenil should be applied 1–2 times a day, according to the doctor's opinion, after washing and drying the injured part, using the formulation suitable for the location of the injury. The cream is suitable for the treatment of glabra skin, skin folds and mucosa; apply slightly frying. Lorenil cream is preferentially used for dry mycosis: Pityriasis versicolor, erythrax, onicomycosis (in the onicomycosis the cream should be applied with occlusive bandage); cream is suitable for use in male genital mycosis. Treatments with Lorenil must be performed regularly until the complete disappearance of injuries. Lorenil does not grease, does not stain and is easily removable with water.

Conservation

This medicine does not require any special condition of conservation.

Warnings

The use, especially if prolonged, of products for topical use, can give rise to phenomena of sensitization. At the time of the application on the lesion there is a modest burning sensation that disappears quickly.

Interactions

Not known.

Effects

Lorenil is generally well tolerated, both on skin and mucosa; only exceptionally mild and transient erythematous reactions were reported. In case of hypersensitivity reactions or development of resistant microorganisms, the treatment must be stopped. Lorenil in the recommended conditions of use is only poorly absorbed, so systemic repercussions can be excluded.

Overdosing

No overdose cases have been reported.

Although the absorption of the medicinal product is poor, the use of Lorenil during pregnancy and breastfeeding is not recommended except in particular cases and after careful evaluation of the benefit/risk report by the doctor.

Source: Farmadati